Big Health has become the first digital therapeutics company to receive guidance from the National Institute for Health and Care Excellence (NICE), which has recommended Sleepio as a cost-saving option for treating insomnia in a move that heralds a new era in digital medicine. The NICE guidance states that Sleepio, Big Health’s digital therapeutic for insomnia, is a safe and effective treatment for people who would otherwise only have access to the current standard of care, wh

Read more...

Amwell®, a digital care delivery leader, today announced the continued expansion of its ecosystem with the launch of the Amwell Comprehensive Behavioral Health Program, an evidence-based, comprehensive and scalable behavioral health solution that can be tailored to meet specific population needs across the full spectrum of care. Designed to address the growing mental health crisis, the Amwell program enables payers and providers to deliver integrated solutions including virtual therapy an

Read more...

Prosperdtx™, a leader in the emerging field of digital therapeutics providing predictive and personalized continuity of care for cancer patients, announced today that it will be collaborating with health equity researchers from the Office of Minority Health & Health Disparities Research at the Georgetown University Lombardi Comprehensive Cancer Center and Seqster, the leader in patient-centric healthcare technology, to empower patients with real-time access to their health data enab

Read more...

XACT Robotics®, developer of the world’s first and only comprehensive robotic system for interventional radiology, announced today that the XACT ACE® Robotic System received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE® Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures. This clearance expands the company’s already broad indication for CT-guided percutane

Read more...

BD (Becton, Dickinson and Company), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes. Together, the companies will look into applying the OXYCAPT™ technology to the next

Read more...

Ortek Therapeutics, Inc., a leader in developing and commercializing novel oral care technologies, today announced that the Brazilian Patent and Trademark Office has issued a patent covering the Ortek-ECD®, a revolutionary electronic cavity detection device that can detect tooth decay often missed by X-rays. With the addition of this newly issued patent in Brazil, the ECD is now covered by 20 issued patents in major global markets with patents now issued in: the United States, A

Read more...

Somnology Inc., a digital healthcare solutions provider specializing in comprehensive sleep care, has announced its partnership with BodiMetrics, LLC, a purveyor of advanced, wearable biometrics sensors. Through the partnership, Somnology will incorporate BodiMetrics’ cutting-edge medical-grade technology to enhance and improve its SomnoRing® – a wearable sleep tracking ring that is a key component of Somnology’s comprehensive, HIPAA-compliant sleep care solution.

Read more...

Medtronic plc, a global leader in healthcare technology, today announced that it has completed the acquisition of Intersect ENT, expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps. As a result of the close of the transaction announced on Aug. 6, 2021, Medtronic has acquired Intersect ENT's PROPEL™ and SINUVA™ (mometasone furoate)

Read more...